Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study

Overview of attention for article published in The Journal of Headache and Pain, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 9,715 followers.

@nanapurini It can be. I'll attach one study on Emgality, specifically. I think some people also find it lowers their daily severity (vs giving them symptom free days). Some people also find a different anti-CGRP mAb or gepant works better after switchin

12 Nov 2023

Reply Repost Favourite

Open Access UCL Research: Efficacy of galcanezumab in patients with migraine and history of failure to 3-4 preventive medication categories: subgroup analysis from CONQUER study - UCL Discovery https://t.co/QkymqHHWUP

14 Oct 2021

Reply Repost Favourite

Efficacy of galcanezumab in patients with migraine and history of failure to 3–4 preventive medication categories: subgroup analysis from CONQUER study https://t.co/O9LP7lhoix

30 Sep 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.